1.Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study
Shuiping ZHAO ; Fang WANG ; Kan YANG ; Yuming HAO ; Guangping LI ; Ming YANG ; Zhenyu YANG
Chinese Journal of Internal Medicine 2014;53(6):455-459
Objective To assess the efficacy and safety of fluvastatin sodium extended-release tablets (fluvastatin XL) 80 mg once daily compared to fluvastatin sodium immediate-release capsules (fluvastatin IR) 40 mg twice daily in Chinese hyperlipidemic patients with moderate or high cardiovascular risk.Methods In this multi-center,randomized,double-blind,double-dummy,active-controlled,parallel-group study,after 6-week open-label treatment with fluvastatin IR 40 mg once daily,patients who did not reach their lipid goals were randomized to 12-week double-blind treatment with fluvastatin XL 80 mg once daily or fluvastatin IR 40 mg twice daily.Results (1) There were 218 patients enrolled in each group.At the study endpoint,no statistical difference was found in the mean percent change from baseline for LDL-C with-8.69% [from (3.504 ±0.060) mmol/L to (3.153 ±0.065) mmol/L] in the fluvastatin XL group and-7.89% [from (3.491 ±0.050) mmol/L to (3.181 ±0.060) mmol/L] in the fluvastatin IR group (P > 0.05).The 95% CI for difference between the two groups in adjusted mean percent change from baseline was (-4.70%-3.09%),which was within the pre-specified non-inferiority margin.In the fluvastatin XL group,the proportion of patients with moderate cardiovascular(CV) risk and high CV risk achieving their LDL-C treatment goals at endpoint was 50.0% and 31.5% respectively,while the proportion was 42.5% and 24.5% respectively in the fluvastatin IR group.No significant difference was found between the two groups in the proportion of patients who reached their lipid goals and the changes from baseline with other lipid parameters.(2)Similar safety profiles were observed in the two treatment groups,with 21.1% adverse event (AE) (8.3% study-drug related AE) in the fluvastatin XL group and 17.0% AE (6.3% study-drug related AE) in the fluvastatin IR group.Conclusion The efficacy of fluvastatin XL 80 mg once daily is comparable to fluvastatin IR 40 mg twice daily in Chinese hyperlipidemic patients with moderate or high cardiovascular risk and both treatments are safe and well-tolerated.
2.Clinicopathologic analysis of 60 cases of pityriasis lichenoides et varioliformis acuta
Xiulian XU ; Guangping WANG ; Hao CHEN ; Yiqun JIANG ; Xuesi ZENG ; Hong JIA ; Jianfang SUN
Chinese Journal of Dermatology 2015;48(2):90-93
Objective To explore the clinicopathologic features of pityriasis lichenoides et varioliformis acuta (PLEVA).Methods A retrospective analysis was performed.Clinical and histological data were collected from 60 patients with PLEVA.The clinicopathologic features of PLEVA were analyzed.Results Among the 60 patients with PLEVA,32 (53.3%) were aged 2-18 years,and 28 (46.7%) aged 19-49 years.Skin lesions were distributed in a diffuse pattern in 50 (83.3%) patients,in a central pattern in 2 (3.3%) patients,and in a peripheral pattern in 8 (13.4%) patients.Nineteen (31.6%) patients had a history of upper respiratory infection.Histopathological examination revealed liquefactive degeneration of basal cells and perivasculitis in the dermis in all the 60 cases,neutrophil abscess formation in the stratum corneum in 26 (43.3%) cases,keratinocyte necrosis in the epidermis in 41 (68.3%) cases,generalized liquefactive degeneration in 30 (50.0%) cases,migration of lymphocytes into the epidermis in 43 (71.6%) cases,Pautrier's microabscess formation in 2 cases,varying degrees of extravasation of erythrocytes into the epidermis in 46 (76.7%) cases,fibrinoid necrosis of blood vessel walls in the dermis in 3 cases.PLEVA progressed into granuloma fungoides in 1 patient.Twenty patients underwent immunohistochemical examination,and 3 of them showed monoclonal hyperplasia of T cells.Conclusions PLEVA has characteristic clinical manifestations,and the combination of pathological and clinical examination is the gold standard for its diagnosis.
3.MicroRNA expression profiles in early mycosis fungoides
Guangping WANG ; Nana NI ; Xiaowei ZHOU ; Ying YANG ; Hao SONG ; Sijian WEN ; Hao CHEN ; Xiulian XU ; Jianfang SUN
Chinese Journal of Dermatology 2016;49(11):785-788
Objective To screen microRNAs(miRNAs)related to early mycosis fungoides(MF). Methods A high?throughput miRNA PCR array was used to determine miRNA expression profiles in skin lesions of 6 patients with early MF (early MF group) and 6 patients with lichen planus (control group), followed by screening of differentially expressed miRNAs between the two groups. Then, real?time fluorescence?based quantitative PCR(RT?qPCR)was performed to verify the differentially expressed miRNAs in lesional specimens from 13 patients with early MF and 13 patients with eczema or lichen planus, as well as in Myla cells and normal human T?lymphocytes. Results The high?throughput miRNA PCR array showed that the expressions of hsa?miR?378a?5p, hsa?miR?107 and hsa?miR?302c?3p were significantly higher in the early MF group than in the control group(all P<0.05). For skin lesions, the results from RT?qPCR were similar to those from the miRNA array assay. Compared with normal human peripheral blood T?lymphocytes, Myla cells showed significantly increased expressions of hsa?miR?378a?5p and hsa?miR?107, which was consistent with the results from the miRNA array assay. However, no significant difference was observed in the expression of hsa?miR?302c?3p between the two kinds of cells. Conclusion MiRNA expression profiles in early MF are different from those in inflammatory skin diseases.
4.Summary of the 16th Chinese Symposium on Burn Medicine and the 2021 Congress of Burn Medicine Branch of China International Exchange and Promotion Association for Medical and Healthcare and the 2021 International Summit Forum of Burns in Chongqing
Yu MO ; Xilan LI ; Jue WANG ; Cheng CHEN ; Weifeng HE ; Hao GUAN ; Gaoxing LUO ; Guangping LIANG
Chinese Journal of Burns 2021;37(6):596-600
The 16th Chinese Symposium on Burn Medicine and the 2021 Congress of Burn Medicine Branch of China International Exchange and Promotion Association for Medical and Healthcare (CPAM) and the 2021 International Summit Forum of Burns in Chongqing was successfully held in Chongqing, from May 19th to 21st in 2021. A total of more than 500 specialists and scholars across the country attended the meeting. The theme of this congress was "Burn Medicine: standardization and internationalization" . With the meetings being held in the one main venue and three branch venues and elite forum, the related hot topics and difficult problems were discussed warmly in multiple dimensions. During the conference, Founding Congress of 6th Editorial Committee of Chinese Journal of Burns, the Standing Committee and whole Committee of Chinese Burn Association, and the Congress of Burn Medicine Branch of CPAM were held in pragmatic and efficient manners.
5.SWOT analysis of"1233"ideological and political teaching reform in Medical Immunology
Guangping HAO ; Yunqing REN ; Changyan CHE ; Hehua YOU
Chinese Journal of Immunology 2024;40(6):1265-1270
As an online and offline mixed teaching method,the"1233"ideological and political teaching reform in Medical Immunology can improve students'independent learning ability,thinking ability,practical ability,ideological and political literacy.It has been piloted on a large scale at Fenyang College of Shanxi Medical University.Moreover,the quality course on the Wisdom Tree online platform has been recognized as the second batch of national first-class quality course.Currently,thirty universities have chosen this quality course.Starting from the actual development of the current"1233"ideological and political teaching reform,this paper uses the SWOT analysis method to systematically analyze the internal advantages and weaknesses,as well as the opportunities and threats of the external competitive environment of the course.Based on this,propose some relevant improvement suggestions and directions,and provide important support for the subsequent optimization and improvement of"1233"ideological and political teaching reform in Medical Immunology.
6. Summary of the 15th Syposium on Chinese Burn Medicine and the 2nd Congress of Burn Medicine Branch of China International Exchange and Promotion Association for Medical and Healthcare
Yu MO ; Jiandong SU ; Bingwei SUN ; Hao GUAN ; Weifeng HE ; Guangping LIANG ; Yizhi PENG
Chinese Journal of Burns 2019;35(7):557-559
The 15th Syposium on Chinese Burn Medicine and the 2nd Congress of Burn Medicine Branch of China International Exchange and Promotion Association for Medical and Healthcare (CPAM) was successfully held in Suzhou, from June 20th to 22th in 2019. A total of 400 specialists and scholars across the country attended the meeting. Focusing on the theme of " Guide and consensus: exploration and consideration " , with form of one main meeting place and two branch meeting places, the related hot and difficult problems were discussed warmly. During the conference, Working Conference of Editorial Committee of